The Institute for Vaccine Safety was established in 1997 at the Johns Hopkins University School of Public Health. Our mission is to independently assess vaccines and vaccine safety to help guide decision makers and educate physicians, the public and the media about key issues surrounding the safety of vaccines. The institute’s goal is to work toward preventing disease using the safest vaccines possible.
IVS Director, Dr. Daniel Salmon, and co-authors discuss vaccine pharmacovigilance programs and make recommendations on how to fund and improve safety systems into the future. The recently published article, Lessons Learned from COVID-19, H1N1, and Routine Vaccine Pharmacovigilance in the United States: A Path to a More Robust Vaccine Safety Program, describes the key characteristics of vaccine pharmacovigilance programs, reviews U.S. vaccine pharmacovigilance for routine vaccination programs, COVID-19, and H1N1, and makes recommendations for improving future vaccine safety systems.
Institute for Vaccine Safety
Johns Hopkins Bloomberg School of Public Health
615 N Wolfe Street
Baltimore, MD 21205
USA
info@vaccinesafety.edu
All rights reserved.